EP2136801
Kappa-ópíumskyld gerandefni til meðferðar á niðurgangs-ríkjandi og víxlandi ristilertingarheilkenni
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
7.3.2008EP published:
29.8.2012EP application number:
08731748.3
EP translation filed:
2.10.2012Grant published:
15.10.2012EPO information:
European Patent Register
Max expiry date:
6.3.2028Expiry date:
6.3.2015
Title:
KAPPA-OPIATE AGONISTS FOR THE TREATMENT OF DIARRHEA-PREDOMINANT AND ALTERNATING IRRITABLE BOWEL SYNDROME
Timeline
Today
7.3.2008EP application
29.8.2012EP Publication
2.10.2012Translation submitted
15.10.2012Registration published
6.3.2015Expires
Owner
Name:
Tioga Pharmaceuticals, Inc.Address:
9393 Towne Centre Dr., Suite 200, 92121, San Diego, CA, US
Inventor
Name:
MANGEL, AllenAddress:
San Diego, CA, US
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
920841 PDate:
30.3.2007Country:
US
Classification
Categories:
A61K 31/4015, A61K 31/40
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 5.2.2013
Expires: 6.3.2014
Payer: Sigurjónsson & Thor ehf.
Number: 7
Paid: 7.2.2014
Expires: 6.3.2015
Payer: Árnason Faktor